PL EN


2013 | 4 | 552-555
Article title

Antibiotic consumption pattern in a single neonatal care unit

Content
Title variants
Languages of publication
EN
Abstracts
Keywords
Contributors
References
  • Warrier I, Du W, Natarajan G. Patterns of drug utilization in a neonatal intensive care unit. J Clin Pharmacol 2006; 46:449–455.
  • Mussi-Pinhata M, Nascimento S. Neonatal nosocomial infections. J Pediatria (Rio J) 2001; 77(Suppl. 1): S81–S96.
  • Fishman NO. Antimicrobial management and cost containment. In: Mandell GE, Bennet JE, Dolin R, eds. Principles and practice of infectious diseases. 5th ed. London: Churchill Livingstone; 2001: 539–546.
  • Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Ann Intern Med 2001; 134: 298–314.
  • Roder BL, Nielsen SL, Magnussen P, et al. Antibiotic usage in an intensive care unit in a D anish university hospital. J Antimicrob Chemother 1993; 32: 633–642.
  • Clark RH , Bloom BT, Spitzer AR, et al. Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death. Pediatrics 2006; 177: 67–72.
  • Arnold C. Decreasing antibiotic overuse in neonatal intensive care units: quality improvement research. MUMC Proceedings 2005; 18: 280–284.
  • Hryniewicz W, Ozorowski T. Hospital antibiotic policy. Proposals for Polish hospitals. www.antybiotyki.edu.pl (avaiable 12 July 2012) [in Polish
  • Ołdak E, Roźkiewicz D, Domański M, et al. Antibiotic use in pediatric teaching hospital of north – eastern Poland in 2004 through 2005. Przegl Ped 2007; 37(2): 195–200.
  • Liem TB, Krediet T, Fleer A, et al. Variation in antibiotic use in neonatal intensive care units in the Netherlands. J Antimicrob Chemother 2010; doi:10.1093/jac/dkq107.
  • Zhang W, Shen X, Bergman U. Drug utilisation 90% (DU 90%) profiles of antibiotics in five Chinese children’s hospitals (2002–2006). Int J Antimicrob Agents 2008; 32: 250–255.
  • Palcevski G, Ahel V, Vlahovic-Palcevski V. Antibiotic use profile at paediatric clinics in two transitional countries. Pharmacoepidemiol Drug Saf 2004; 13: 181–185.
  • Bergman U, Popa C, Tomson Y. Drug utilization 90% – a simple method for assessing the quality of drug prescribing. Eur J Clin Pharmacol 1998; 54: 113–118.
  • Nitsch-Osuch A, Pabianek D, Topczewska-Cabanek A, i wsp. Zapalenia opon mózgowo-rdzeniowcyh jako przyczyna hospitalizacji w oddziale intensywnej opieki medycznej wybranego szpitala pediatrycznego w Warszawie w latach 2002–2010. Fam Med Prim Care Rev 2011; 13(2): 200–205.
  • Gordon A, Isaacs D. Late-onset infection and the role of antibiotic prescribing policies. Curr Opin Infect Dis 2004; 7: 231–236.
  • Gruneberg RN , Wilson AP. Anti-infective treatment in intensive care: the role of glycopeptides. Intensive Care Med 1994;20(Suppl. 4): S17–S22.
  • Choroszy-Król I, Frej-Mądrzak M, Teryks-Wołyniec D. Zakażenia układu moczowo-płciowego wywołane przez Chlamydia trachomatis w praktyce lekarza rodzinnego. Fam Med Prim Care Rev 2011; 13(2): 292–295.
  • Liem TB, Heerdink ER , Egberts AC, et al. Quantifying antibiotic use in paediatrics: a proposal for neonatal DDD s. Eur J Microbiol Infect Dis 2010; 29: 1301–1303.
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.desklight-68c21783-bbdb-4f5f-bb6c-86e7c47473bf
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.